November 8, 2017 / 9:39 PM / a month ago

BRIEF-Adverum Biotechnologies posts Q3 loss of $0.32 per share

Nov 8 (Reuters) - Adverum Biotechnologies Inc

* Adverum biotechnologies reports third quarter 2017 financial results and provides corporate update

* Q3 loss per share $0.32

* Q3 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S

* Adverum biotechnologies - ‍cash, cash equivalents,marketable securities were $186.6 million as of sept 30, 2017, versus $197.4 million as of june 30, 2017 ​

* Adverum biotechnologies - ‍current cash position expected to fund 3 lead gene therapy programs through end of 2019 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below